hyposensitization

(redirected from Allergy immunotherapy)
Also found in: Medical.

hyposensitization

[¦hī·pō‚sen·səd·ə′zā·shən]
(communications)
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
Mentioned in ?
References in periodicals archive ?
Summary: This report studies the current as well as future prospects of the global Allergy Immunotherapy Market.
Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites.
OMIT enables consistent delivery of allergy immunotherapy while a user brushes their teeth.
ALK-Abello A/S (ALK)(CPH:ALKB:DC), a pharmaceutical company specialising in the development and manufacture of allergy immunotherapy products for the prevention and treatment of allergy, announced on Friday that it has finalised its strategy for entering the US market for epinephrine (adrenaline) auto-injectors (EAIs) and that this will focus on a new next-generation EAI in partnership with US-based Windgap Medical (Windgap).
ALK Abello A/S (ALK)(CPH:ALKB), a specialty pharmaceutical company focused on allergy and allergic asthma, announced on Friday the successful completion of the marketing authorisation procedure for its tree sublingual allergy immunotherapy (SLIT) tablet in 17 European countries.
What follows are 6 common questions about allergy immunotherapy (AIT) and the evidence-based answers that will help you to identify and treat appropriate candidates, as well as educate them along the way.
ASIT biotech has unveiled positive outcomes and recommendations following the meetings of its scientific advisory boards, bringing together 9 of the most recognized international experts in the field of allergy immunotherapy.
In 2015 Stallergenes and Greer united to form a worldwide leader in allergy immunotherapy, an innovative and sustainable group carrying the name of Stallergenes Greer.
TUESDAY, April 3, 2018 (HealthDay News) -- The majority of caregivers of children with food allergy are willing to consider participation in clinical trials for food allergy immunotherapy, according to a research letter published in the March issue of the Annals of Allergy, Asthma & Immunology.
Practical recommendations for mixing allergy immunotherapy extracts.
Allergy immunotherapy, by either subcutaneous injection or sublingual tablets, is the most effective long-term treatment for dust mite allergies.

Full browser ?